Business
Dario Achieves Goal of 100 Business-to-Business Contracts in 2022
Northeast supermarket chain will deploy Dario's cardiometabolic suite in 2023 NEW YORK, Jan. 3, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario"
About this update from Dariohealth Corp.
[{"type":"text","content":"Northeast supermarket chain will deploy Dario's cardiometabolic suite in 2023\nNEW YORK, Jan. 3, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (\"Dario\" or the \"Company\"), a leader in the global digital therapeutics (DTx) market, announced today that a large Northeast U.S. supermarket chain (the \"Employer\") selected Dario to help improve the cardiometabolic health of its employees beginning in the first quarter of 2023, marking the Company reaching 100 enterprise contracts signed. This milestone achievement validates the Company's strategic position as a leading provider of integrated digital chronic condition management solutions in the employer and payer markets.\nThe Employer selected Dario's cardiometabolic suite to support employees living with diabetes, high blood pressure and weight management needs using a holistic approach that combines connected devices, smart technologies and human support to improve overall health.\n\"Throughout 2022 we saw that the demand for our integrated multi-condition solutions grow at a steady pace, and the addition of this Employer marks a tremendous achievement for Dario. Hitting our goal of 100 contracts by the end of 2022 is a testament to the vision we set forth over a year ago. The fact that most of the contracts signed in 2022 and more than 50% of our pipeline are for multiple conditions represents market validation of our multi-condition suite approach. There is a clear trend with enterprise customers seeking multiple conditions from less vendors. Given our multi-condition suite strategy we believe that we are well positioned for growth in the future market,\" said Rick Anderson, President of Dario.\nAbout DarioHealth Corp.\nDarioHealth Corp. (NASDAQ: DRIO) is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition platform. Our platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. \nOur user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainab...